{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:14:38Z","timestamp":1792192478069,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34850","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T21:37:58Z","timestamp":1721252278000},"page":"e34850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Life-threatening amiodarone-induced thyrotoxicosis \u2013 Personalized approach to radical treatment"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5919-9291","authenticated-orcid":false,"given":"Marta","family":"Opali\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Pantofli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Soko\u0142owski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Pach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Kostecka-Matyja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"\u017babicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Party\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Kie\u0107-Klimczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sowa-Staszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Buziak-Bereza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Gilis-Januszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5208-4689","authenticated-orcid":false,"given":"Alicja","family":"Hubalewska-Dydejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.heliyon.2024.e34850_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40256-020-00401-5","article-title":"Amiodarone: a comprehensive guide for clinicians","volume":"20","author":"Hamilton","year":"2020","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34850_bib2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.heliyon.2024.e34850_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1874192401307010122","article-title":"Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy: experience at a tertiary care centre in oman","volume":"7","author":"Farhan","year":"2013","journal-title":"Open Cardiovasc. Med. J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34850_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34850_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34850_bib6","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34850_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2007.02920.x","article-title":"Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy","volume":"67","author":"Bogazzi","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e34850_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.14740\/jem278w","article-title":"Mixed amiodarone-induced thyrotoxicosis refractory to medical therapy and plasmapheresis","volume":"5","author":"Kotwal","year":"2015","journal-title":"J Endocrinol Metab"},{"issue":"24","key":"10.1016\/j.heliyon.2024.e34850_bib9","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2007.02.054","article-title":"Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome","volume":"49","author":"Conen","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34850_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/CCM.0000000000004078","article-title":"Thyroid storm in the ICU: a retrospective multicenter study","volume":"48","author":"Bourcier","year":"2020","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34850_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486957","article-title":"2018 European thyroid association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction","volume":"7","author":"Bartalena","year":"2018","journal-title":"Eur. Thyroid J."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34850_bib12","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/js.2018-00259","article-title":"Thyroidectomy for amiodarone-induced thyrotoxicosis: mayo clinic experience","volume":"2","author":"Kotwal","year":"2018","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34850_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12020-018-1661-x","article-title":"Therapeutic plasmapheresis in thyrotoxic patients","volume":"62","author":"Simsir","year":"2018","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34850_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14740\/jmc3450","article-title":"Amiodarone-induced thyroid storm causing sustained monomorphic ventricular tachycardia treated with plasmapheresis: a challenging clinical case","volume":"11","author":"Upadhyaya","year":"2020","journal-title":"J. Med. Cases"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34850_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000453578","article-title":"Successful pretreatment using plasma exchange before thyroidectomy in a patient with amiodarone-induced thyrotoxicosis","volume":"6","author":"Tonnelier","year":"2017","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.heliyon.2024.e34850_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-022-01897-1","article-title":"Therapeutic plasma exchange in hyperthyroidism prior to surgery","author":"Kirkizlar","year":"2022","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34850_bib17","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-21-0007","article-title":"Thyroid arterial embolization in a patient with congenital heart disease and refractory amiodarone-induced thyrotoxicosis","volume":"11","author":"Bou\u00e7a","year":"2022","journal-title":"Eur. Thyroid J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34850_bib18","first-page":"119","article-title":"Invasive heart rate control as a salvage therapy in amiodarone-induced thyroid storm","volume":"37","author":"Ozcan","year":"2022","journal-title":"Medeni Med J"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34850_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2265.1996.00566.x","article-title":"Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted amiodarone-induced thyroiditis","volume":"45","author":"Samaras","year":"1996","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34850_bib20","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz041","article-title":"Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis","volume":"105","author":"Cappellani","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34850_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1089\/thy.2016.0500","article-title":"Postoperative outcomes in Graves' disease patients: results from the nationwide inpatient sample database","volume":"27","author":"Rubio","year":"2017","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34850_bib22","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/hed.26148","article-title":"Total thyroidectomy: safe and curative treatment option for hyperthyroidism","volume":"42","author":"Frank","year":"2020","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34850_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/a-0577-7574","article-title":"Amiodarone-induced thyroid dysfunction: a clinical update","volume":"126","author":"Elnaggar","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34850_bib24","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.amjcard.2016.01.003","article-title":"Amiodarone-induced thyrotoxicosis recurrence after amiodarone reintroduction","volume":"117","author":"Maqdasy","year":"2016","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34850_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.20452\/pamw.2556","article-title":"Radioiodine therapy in patients with type II amiodarone-induced thyrotoxicosis","volume":"124","author":"Czarnywojtek","year":"2014","journal-title":"Pol. Arch. Med. Wewn."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34850_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2265.2009.03600.x","article-title":"Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis: a cautionary note","volume":"72","author":"Bogazzi","year":"2010","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34850_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40261-017-0582-4","article-title":"Asociation between serum amiodarone and N-desethylamiodarone concentrations and development of thyroid dysfunction","volume":"38","author":"Yamato","year":"2018","journal-title":"Clin. Drug Invest."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402410881X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402410881X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:36:16Z","timestamp":1773840976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402410881X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":27,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S240584402410881X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34850","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Life-threatening amiodarone-induced thyrotoxicosis \u2013 Personalized approach to radical treatment","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Jagiellonian Univerity Medical College. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34850"}}